Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Filter Results

1383 News Releases Found

Constantine Mitsiades, MD, PhD
News Releases
5/26/2023

CRISPR studies identify many promising therapeutic targets for multiple myeloma

  • Multiple Myeloma
_
News Releases
5/26/2023

Breast, rectal, kidney and brain cancer phase 3 trials headline Dana-Farber research at ASCO Annual Meeting

  • Research
_
News Releases
5/25/2023

Women with breast cancer shed pounds thanks to telephone-based weight loss program, clinical trial finds

  • Research
  • Breast Cancer
_
News Releases
5/24/2023

2nd Transatlantic Exchange Program focusses on Artificial Intelligence and Data Science in Oncology

  • Discovery
_
News Releases
5/22/2023

The Jimmy Fund Celebrates 75 years of Progress and Impact on May 22

News Releases
5/16/2023

Dana-Farber researchers report on the safety and activity of immune checkpoint inhibitors in people living with HIV and cancer

_
News Releases
5/12/2023

Mass General Brigham and Dana-Farber Cancer Institute collaborating with BEEAH Group to advise on a new, patient-centered health care system

L to R: Christopher Lathan, MD, MS, MPH, Chief Clinical Access and Equity Officer##SEMICOLON## Magnolia Contreras, MSW, MBA — VP, Community Health##SEMICOLON## Joyce F. Liu, MD, MPH — Gynecologic Oncology##SEMICOLON## Erica L. Mayer, MD, MPH — Breast Oncology##SEMICOLON## Rachel A. Freedman, MD, MPH — Breast Oncology##SEMICOLON## Alexi A. Wright, MD, MPH — Gynecologic Oncology
News Releases
5/11/2023

Boston women unite to discuss how Dana-Farber is addressing inequities in breast and gynecologic cancer care

  • Inclusion, Diversity & Equity
  • Gynecologic Cancer
  • Breast Cancer
_
News Releases
5/10/2023

Three-drug combination slows progression of advanced kidney cancer

  • Research
  • Immunotherapy
  • Kidney Cancer